Creative Touch Permanent Makeup and Aesthetics

Glycosaminoglycans (GAGs) are the dermis’s most powerful humectants . They are the reason the dermis is 70% water by weight despite being structurally solid. They are unbranched polysaccharide chains built from repeating disaccharide units – each pair consisting of an amino sugar and a uronic acid (or galactose) – whose dense negative charge, from carboxylate and sulfate groups, attracts and retains water molecules at concentrations far exceeding their own mass. Five GAG classes exist in human skin: hyaluronic acid (HA), chondroitin sulfate (CS), dermatan sulfate (DS), heparan sulfate (HS), and keratan sulfate (KS) – each with a distinct disaccharide composition, sulfation character, and tissue function. Four of these five are synthesised as covalent attachments to proteoglycan core proteins; HA alone is synthesised as a free chain at the plasma membrane by hyaluronan synthases. The sulfation pattern of each GAG chain – the positional and density code of its sulfate groups – is not structural decoration: it determines which growth factors, cytokines, and signalling proteins bind to the chain, making sulfation the information-coding mechanism of the GAG system. In aged skin, GAGs decline both quantitatively (shorter chains, lower total content) and qualitatively (altered sulfation ratios) – changes that reduce hydration, impair collagen architecture, disrupt growth factor sequestration, and compromise the ECM environment that fibroblasts and keratinocytes operate within.

The dermis does not hold water because it is wet – it holds water because it is built from molecules whose chemistry makes water retention a structural property of the tissue itself. GAGs are those molecules. A single hyaluronic acid chain can bind many times its own weight in water; sulfated GAG chains on decorin and versican contribute additional water-retention capacity whilst simultaneously organising the collagen and elastic fibres they associate with. The result is a dermis that is simultaneously hydrated, resilient under compression, and capable of rapid elastic recovery – properties that depend not on any single GAG molecule but on the integrated GAG system operating at the right concentration, chain length, and sulfation pattern. When any of these three variables deteriorate with age, the mechanical and biological properties of the dermis deteriorate with them, regardless of whether collagen and elastin content is yet measurably affected. ^[18]

Are Glycosaminoglycans Humectants?

GAGs are humectants. The mechanism is electrochemical rather than incidental: each GAG chain carries immobilised negative charges from carboxylate groups (present in all five GAG classes) and sulfate groups (present in chondroitin sulfate, dermatan sulfate, heparan sulfate, and keratan sulfate). In aqueous tissue, these fixed negative charges attract mobile cations – primarily Na⁺ – from the surrounding interstitial fluid. To maintain electrochemical equilibrium, water follows the ion gradient inward. This is Donnan osmotic pressure: a net inward force generated by the charge density of the GAG chains that drives the surrounding matrix to continuously imbibe and retain fluid. Direct membrane osmometry of chondroitin sulfate solutions at physiological ionic strength (0.15 M NaCl) demonstrates that osmotic pressure increases nonlinearly with fixed charge density, and that the Donnan contribution dominates under all in vivo ionic conditions – configurational entropy becomes the primary contributor only at salt concentrations far exceeding anything found in dermal tissue. ^[5]

At the tissue level, osmotic gradients generated by GAG chains develop across the dermal layers at micrometre-to-millimetre scales, and local GAG concentration determines the regional water-holding capacity and resistance to fluid transfer. Pressure-volume measurements in human dermis confirm that the interstitial fluid compartment is maintained under controlled osmotic tension by GAG charge density; when GAG content falls – as it does progressively with intrinsic ageing and photoageing – dermal water content, volume, and mechanical compliance decline as a direct consequence of reduced Donnan pressure. ^[10] Recent work using MRI-based assessment and mechanical testing confirms that water and ion binding to proteoglycan chains is the dominant mechanism by which the ECM resists deformation and recovers from compressive load – a property that deteriorates measurably as GAG content declines with age. ^[7]

Hyaluronic acid as the dermis’s primary humectant. Among the five GAG classes, HA accounts for approximately 50% of total skin GAG content and constitutes the quantitatively dominant humectant in skin. Unlike the sulfated GAGs, HA carries only carboxylate-group charge and binds water primarily through hydrogen bonding rather than electrostatic interaction – a mechanism that generates high-viscosity hydrogels at low concentrations and contributes substantial osmotic holding capacity within the dermal ECM. ^[14] The frequently cited figure of HA retaining “1,000 times its own weight in water” warrants scrutiny here: this figure originates from hydrodynamic volume data describing the enormous solution volume a single HA chain occupies at low concentration due to its coiled molecular configuration – not from direct measurement of bound water mass. The Donnan osmotic pressure mechanism described above is a more mechanistically accurate account of how HA holds water in dermal tissue than any single mass-ratio figure, and the clinically relevant point is that HA’s water-retention capacity is sufficiently large to account for the majority of dermal hydration – and that its progressive depletion with age reduces dermal water content, turgor, and volume through a directly measurable mechanism. ^[14] The high charge density across the full GAG system – carboxylate in HA, carboxylate plus sulfate in CS, DS, and HS – enables electrostatic water retention across multiple dermal compartments, and the structural integrity of each GAG class determines its contribution to regional hydration. ^[15]

Topical versus dermal humectancy. The distinction between surface humectancy and dermal GAG function is clinically meaningful. Topical humectants – HA serums, glycerin, urea – act at the level of the stratum corneum, where direct evidence supports their use and where they perform reliably. The dermal GAG system operates within the extracellular matrix, at depths topical products do not reach in intact, functionally meaningful form. ^[14] Skin presenting with surface dryness that responds to topical hydration support represents a different clinical picture from skin presenting with loss of dermal volume, reduced mechanical resilience, and inadequate response to topical products. The second presentation reflects structural GAG depletion – reduced decorin chain length, lower total uronic acid content, altered sulfation patterns – that requires a categorically different intervention. See the therapeutic stimulation of GAG synthesis below for the treatment implications of this distinction.

Types of Glycosaminoglycans

The five GAG classes differ in their disaccharide units, sulfation character, whether they are attached to a proteoglycan core, and their primary locations in skin.

CS and DS are structurally near-identical – DS contains iduronic acid (IdoUA) in place of glucuronic acid (GlcUA) and historically were classified as variants of the same chain until their distinct biological roles were established. Both share the same tetrasaccharide linker and serine attachment point on their proteoglycan core proteins. Heparan sulfate is structurally similar to heparin but organised into alternating sulfated and non-sulfated domains rather than heparin’s uniformly dense sulfation – a distinction with significant functional consequences for its growth factor binding behaviour. ^[4]

Sulfation as information. The degree and positional pattern of sulfation on a GAG chain determines its binding specificity for growth factors, cytokines, and signalling proteins. HS sulfation codes – the precise arrangement of 2-O, 6-O, and N-sulfate groups – create specific binding sites for FGF2, FGF7, VEGF, and HGF isoforms that differ by only a few sulfate positions. CS sulfation codes (4-O vs 6-O) influence collagen fibrillogenesis and ECM organisation at the fibril level. GAGs are not inert structural fillers – they are information-coded ECM components whose signal-regulatory capacity is written in their sulfation pattern. ^[1]

GAG distribution in skin

GAGs constitute approximately 0.1–0.3% of total skin dry weight – a small fraction by mass, but the dominant determinant of dermal water-holding capacity and growth factor availability. The dermis contains approximately 6–7 times more GAG than the epidermis by wet weight. HA constitutes approximately 50% of all skin GAG in young adults; the remainder is sulfated GAG associated with proteoglycan core proteins. Of the sulfated GAGs in dermis, CS and DS predominate – the majority directly associated with collagen fibrils via decorin. HS and KS are present at comparatively low levels, with HS concentrated at the basement membrane zone. The epidermis has a distinct GAG profile from the dermis: relatively high C4S and HS throughout, with C6S uniquely expressed in the basal layer. ^[18]

The principal GAG-carrying proteoglycans in skin are:

• Decorin – carries DS and CS chains; colocalises with and directly regulates collagen fibrils; decorin GAG chains govern collagen fibril diameter and interfibrillar spacing, making adequate decorin GAG chemistry a prerequisite for mechanically functional collagen architecture
• Versican – carries CS chains; colocalises with elastic fibres in the papillary and reticular dermis; the large aggregating proteoglycan of the dermal ECM
• Perlecan – carries HS chains; concentrated at the basement membrane zone; its HS chains sequester and present FGF2, VEGF, and HGF to cell surface receptors, acting as the ECM growth factor reservoir
• Biglycan – carries CS/DS chains like decorin; the second most abundant small leucine-rich proteoglycan (SLRP) in skin; less well characterised than decorin but contributes to the sulfated GAG pool

Glycosaminoglycan function in skin

Hydration and turgor. The negatively charged carboxylate and sulfate groups on GAG chains attract water molecules via osmotic and electrostatic forces, retaining water at concentrations far exceeding the GAG mass itself. The negatively charged carboxylate and sulfate groups on GAG chains generate Donnan osmotic pressure within the dermal ECM, attracting and retaining interstitial fluid at concentrations far exceeding GAG mass. The dermal water content that determines skin volume, suppleness, and resistance to mechanical deformation is a direct function of GAG concentration, chain length, and charge density – see Are Glycosaminoglycans Humectants? above for the mechanistic detail. The dermal water content that determines skin volume, suppleness, and resistance to mechanical deformation is a direct function of GAG concentration, chain length, and integrity. ^[18]

Collagen fibril organisation. Decorin’s DS/CS chains regulate collagen fibril diameter and interfibrillar spacing by controlling the rate of lateral fibril association during fibrillogenesis. Without adequate decorin GAG, collagen fibrils aggregate into abnormally thick, disorganised bundles with reduced tensile strength – a structural failure demonstrated directly in decorin-null mouse models. The sulfated GAGs of dermis are not passengers in the collagen matrix; they are active regulators of its architecture. ^[17]

Growth factor sequestration and presentation. HS chains on perlecan and other basement membrane proteoglycans act as co-receptors and ECM reservoirs for FGF2, FGF7, VEGF, HGF, and TGF-β. These growth factors bind the HS chains with specificity determined by the HS sulfation pattern, forming a slow-release depot that sustains fibroblast and keratinocyte stimulation between acute signalling events. Loss of HS integrity – through heparanase activity in inflammation or UV exposure – simultaneously depletes the growth factor reservoir and releases bound factors in an uncontrolled burst that promotes inflammatory signalling rather than homeostatic repair.

Inflammatory modulation and anti-apoptotic signalling. GAGs regulate cytokine and chemokine gradients in the ECM via charge-based sequestration. Exogenous GAGs inhibit TNF-α-induced ERK/AP-1 signalling in dermal fibroblasts, reducing both collagen degradation and fibroblast apoptosis – a mechanism relevant to the inflammatory microenvironment of aged and senescent skin where TNF-α is chronically elevated as part of SASP. ^[12]

Glycosaminoglycan synthesis

All sulfated GAGs are assembled in the Golgi apparatus through a sequence of enzyme-catalysed steps that build, extend, and chemically modify each chain on its proteoglycan core protein. HA is synthesised by an entirely separate mechanism at the plasma membrane. The distinction matters clinically because the two pathways are regulated by different upstream signals and respond to different therapeutic interventions. ^{[4] [11]}

Sulfated GAG synthesis (CS, DS, HS, KS) – five steps:

1. UDP-sugar synthesis. Nucleotide-activated sugars (UDP-GlcUA, UDP-GalNAc, UDP-GlcNAc, UDP-Xyl) are synthesised in the cytoplasm. UDP-xylose – the initiator sugar – is formed specifically by UDP-GlcUA decarboxylase in the ER membrane, making it the first committed step in the pathway.

2. Transport into the Golgi lumen. UDP-sugars cannot cross the Golgi membrane unaided; dedicated nucleotide sugar transporters (NSTs) carry each UDP-sugar into the Golgi lumen via an antiport mechanism – one UDP-sugar in, one nucleotide monophosphate out.

3. Tetrasaccharide linker assembly on the core protein. All CS, DS, and HS chains begin identically: xylosyltransferase I or II (XylT1/XylT2) attaches xylose to a specific serine residue on the proteoglycan core protein. Two galactose residues and one glucuronic acid are then added sequentially by dedicated galactosyltransferases and GlcA-transferase, forming the tetrasaccharide linker: GlcUA-Gal-Gal-Xyl-Ser. This linker is shared by all CS, DS, and HS chains – the GAG class produced is not determined here but in the next step. XylT1/XylT2 activity is the rate-limiting step for sulfated GAG production overall.

4. Chain elongation and class determination. GAG-specific glycosyltransferases then add alternating sugar units to extend the chain. The specific combination of transferases recruited to the growing chain determines whether CS, DS, or HS is produced. After initial chain extension as CS, C5-epimerase converts a proportion of GlcUA residues to IdoUA – the epimerisation step that converts CS to DS. The extent of C5-epimerase activity determines the CS:DS ratio on each proteoglycan, which varies by proteoglycan type, tissue, and age.

5. Sulfation – the information-coding step. Sulfotransferases transfer sulfate groups from the donor PAPS (3′-phosphoadenosine-5′-phosphosulfate) to specific positions on the sugar units. For CS: C4-sulfotransferase (C4ST) adds 4-O-sulfate; C6ST adds 6-O-sulfate – the ratio of 4-O to 6-O sulfation shifts measurably with age, independently of chain length changes. For HS: NDST1/2 performs N-deacetylation and N-sulfation of GlcNAc residues; HS2ST and HS6ST add 2-O and 6-O sulfate groups. Each positional sulfation event creates or destroys a binding site for a specific growth factor or signalling protein. This step is not post-translational decoration – it is the molecular writing of the GAG signalling code.

Hyaluronic acid synthesis – the Golgi-independent exception. HA is synthesised at the inner face of the plasma membrane by three hyaluronan synthases: HAS1, HAS2, and HAS3. Each HAS enzyme extends the HA chain by alternately adding UDP-GlcNAc and UDP-GlcUA from the cytoplasm, simultaneously extruding the growing chain through the membrane into the extracellular space. No protein core attachment, no Golgi processing, no sulfation. HAS2 is the predominant isoform in adult dermal fibroblasts; its expression is upregulated by TGF-β, EGF, and – in the context of mechanical load – by compressive force transduced through CD44, the primary HA cell-surface receptor. ^[4]

Regulation and rate-limiting steps. XylT1/XylT2 controls the entry rate of all sulfated GAG chains into biosynthesis and is the primary target of upstream stimulatory signals. TGF-β upregulates XylT expression and chain elongation enzyme activity in dermal fibroblasts – the primary mechanism through which TGF-β drives ECM production in wound healing. Retinoic acid stimulates GAG biosynthesis via RAR/RXR signalling in keratinocytes and fibroblasts with a cyclical temporal profile – peak output days 11, 25, and 36 after treatment onset, suggesting episodic transcriptional upregulation rather than a sustained increase. EGF, IGF-1, and FGF2 stimulate HAS2 expression specifically, driving HA synthesis independently of sulfated GAG pathways. ^{[16] [6]}

GAG decline in ageing and photodamage

GAG depletion may be one of the earliest measurable ECM changes in skin ageing – in some anatomical regions preceding the collagen and elastin losses that are more commonly described. The decline operates through three concurrent mechanisms: reduced total content, shorter chain length, and altered sulfation patterns. ^[2]

Quantified decline in intrinsic ageing. Epidermal HA, dermal total sulfated GAG, and total uronic acid content all decrease measurably with intrinsic ageing. Skin water content correlates positively with HA and tsGAG in the epidermis – the hydration loss of aged skin has a direct GAG substrate basis rather than being solely attributable to reduced barrier function. A gender difference emerges in the data: epidermal tsGAG, tUA, and tissue water decrease significantly in aged females but not in aged males at the same ages, implicating post-menopausal oestrogen withdrawal as a contributing mechanism independent of chronological age alone. ^[13]

Decorin GAG chain shortening. In aged human skin, total sulfated GAG content is significantly reduced – but the decorin core protein itself is not significantly depleted. The GAG chains attached to decorin are shorter in aged skin than in young skin; the protein carrier is present but its polysaccharide chains have been truncated by extracellular glycosidase activity. Since decorin-associated GAG constitutes the majority of dermal sulfated GAGs, the bulk of the age-related sulfated GAG decline in dermis reflects chain shortening of existing decorin, not decorin protein loss. The collagen fibril organisation that depends on decorin GAG chain chemistry is therefore compromised not because decorin is absent but because its functional component is diminished. ^[8]

Altered sulfation patterns. Versican shows age-related changes in GAG chain size and sulfation pattern that are qualitative rather than purely quantitative – the chains change character with age independently of their length reduction. The CS 4-O/6-O sulfation ratio shifts measurably with ageing, altering the signalling capacity of CS chains and their interactions with growth factors and cell surface receptors. Aged dermis does not simply contain less GAG; it contains GAG that reads differently to the cells and signalling proteins that interact with it. ^[3]

Photoageing acceleration. UV exposure accelerates HA degradation via hyaluronidase upregulation and direct ROS fragmentation of HA chains. Photoaged dermis shows increased levels of pro-inflammatory proteases (including heparanase) alongside reduced ECM proteoglycans – the heparanase-driven HS degradation simultaneously depleting the HS pool and releasing sequestered growth factors in an inflammatory rather than homeostatic context. The laminin-511 and basement membrane HS depletion described in the Stratum Basale entity is part of the same photoageing-driven GAG degradation programme operating at the DEJ. ^[9]

Therapeutic stimulation of GAG synthesis

Clinical Pearl. The clinical conversation about hydration has been dominated by topical humectants – HA serums, glycerin, urea – for long enough that the distinction between supplementing humectants at the surface and restoring the GAG system in the dermis has become blurred. Topical HA does not reach the dermis in intact form at meaningful concentrations; its hydration benefit is at the stratum corneum level, where it performs well. The question of whether a patient’s loss of skin volume, turgor, and resilience is a surface humectant problem or a dermal GAG depletion problem is not answered by either kind of product – it is answered by whether the skin responds to topical barrier support (surface problem) or whether it requires injectable HA supplementation, retinoid-driven GAG synthesis stimulation, or growth factor-pathway activation (dermal problem). Aged skin with measurably reduced dermal volume and resilience that does not respond adequately to sophisticated topical hydration is most likely presenting the clinical consequence of decorin GAG chain shortening, reduced total uronic acid content, and altered CS sulfation patterns in the dermis – none of which a topical humectant addresses, regardless of molecular weight.